Literature DB >> 18627440

Dosing anticoagulant therapy with coumarin drugs: is genotyping clinically useful? Yes.

S M Thacker1, G R Grice, P E Milligan, B F Gage.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18627440     DOI： 10.1111/j.1538-7836.2008.03074.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  5 in total

1.  A vitamin K epoxide reductase-oxidase complex gene polymorphism (-1639G>A) and interindividual variability in the dose-effect of vitamin K antagonists.

Authors:  E Stepien; A Branicka; M Ciesla-Dul; A Undas
Journal:  J Appl Genet       Date:  2009       Impact factor: 3.240

2.  A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans.

Authors:  D Voora; D C Koboldt; C R King; P A Lenzini; C S Eby; R Porche-Sorbet; E Deych; M Crankshaw; P E Milligan; H L McLeod; S R Patel; L H Cavallari; P M Ridker; G R Grice; R D Miller; B F Gage
Journal:  Clin Pharmacol Ther       Date:  2010-03-03       Impact factor: 6.875

Review 3.  Genotype-based dosing algorithms for warfarin therapy: data review and recommendations.

Authors:  Eric G Johnson; Benjamin D Horne; John F Carlquist; Jeffrey L Anderson
Journal:  Mol Diagn Ther       Date:  2011-10-01       Impact factor: 4.074

4.  Genetics informatics trial (GIFT) of warfarin to prevent deep vein thrombosis (DVT): rationale and study design.

Authors:  E J Do; P Lenzini; C S Eby; A R Bass; G A McMillin; S M Stevens; S C Woller; R C Pendleton; J L Anderson; P Proctor; R M Nunley; V Davila-Roman; B F Gage
Journal:  Pharmacogenomics J       Date:  2011-05-24       Impact factor: 3.550

5.  Asymmetrical hybridization and gene flow between Eisenia andrei and E. fetida lumbricid earthworms.

Authors:  Barbara Plytycz; Janusz Bigaj; Tomasz Panz; Paweł Grzmil
Journal:  PLoS One       Date:  2018-09-21       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.